Elsevier

Human Pathology

Volume 30, Issue 3, March 1999, Pages 313-323
Human Pathology

Original contribution
The immunohistochemical diagnosis of epithelial mesothelioma

https://doi.org/10.1016/S0046-8177(99)90011-4Get rights and content

Abstract

Although it is generally accepted that immunohistochemistry can assist in distinguishing between epithelial mesotheliomas and metastatic adenocarcinomas to the serosal membranes, a great deal of controversy exists regarding not only the practical value of some of the markers currently used, but also which should be included as part of the routine diagnostic panel. Until recently, these panels consisted primarily of antibodies that stained adenocarcinomas but not mesotheliomas. Over the last few years, however, markers that are commonly expressed in mesotheliomas but not in adenocarcinomas have been recognized. The focus of this review is on those markers for which there is an indication that they have a practical use in the diagnosis of mesothelioma. Special emphasis is placed on those which have been most recently recognized.

References (107)

  • A Aruffo et al.

    CD44 is the principal cell surface receptor for hyaluronate

    Cell

    (1990)
  • L De Leij et al.

    Immunoperoxidase staining on frozen tissue sections as a first screening assay in the preparation of monoclonal antibodies directed against small cell carcinoma of the lung

    Eur J Cancer Clin Oncol

    (1984)
  • RL Souhami et al.

    Antigens of small-cell lung cancer

  • NG Ordóñez

    Value of the MOC-31 monoclonal antibody in differentiating epithelial pleural mesothelioma from lung adenocarcinoma

    Hum Pathol

    (1998)
  • L Kuhlmann et al.

    Distinction of mesothelioma from carcinoma in pleural effusions: An immunocytochemical study on routinely processed cytoblock preparations

    Path Res Pract

    (1991)
  • A Grove et al.

    The value of immunohistochemistry of pleural biopsy specimens in the differential diagnosis between malignant mesothelioma and metastatic carcinoma

    Path Res Pract

    (1994)
  • MR Wick et al.

    Malignant epithelioid pleural mesothelioma versus peripheral pulmonary adenocarcinoma: A histochemical, ultrastructural, and immunohistologic study of 103 cases

    Hum Pathol

    (1990)
  • PA Ruffie

    Pleural mesothelioma

    Curr Opin Oncol

    (1991)
  • SP Hammar et al.

    Mucin-positive epithelial mesotheliomas: A histochemical, immunohistochemical, and ultrastructural comparison with mucin-producing pulmonary adenocarcinomas

    Ultrastruct Pathol

    (1996)
  • NG Ordóñez et al.

    The roles of immunohistochemistry and electron microscopy in distinguishing epithelial mesothelioma of the pleura from adenocarcinoma

    Adv Anatomic Pathol

    (1996)
  • NG Ordóñez

    Value of antibodies 44-3A6, SM3, HBME-1 and thrombomodulin in differentiating epithelial pleural mesothelioma from lung adenocarcinoma: A comparative study with other commonly used antibodies

    Am J Surg Pathol

    (1997)
  • JR Riera et al.

    The immunohistochemical diagnostic panel for epithelial mesothelioma

  • Leong AS-Y et al.

    The immunohistochemistry of malignant mesothelioma

    Pathol Annu

    (1994)
  • NG Ordóñez

    The immunohistochemical diagnosis of mesothelioma

  • G Singh et al.

    Expression of a 130-kDa mesothelial and ciliated cell Ag (MCp130) in normal and developing human and rat lung and its role as a diagnostic marker for mesotheliomas and tumors of the female reproductive system

    Lab Invest

    (1995)
  • CL Collins et al.

    Thrombomodulin expression in malignant pleural mesothelioma and pulmonary adenocarcinoma

    Am J Pathol

    (1992)
  • C Doglioni et al.

    Calretinin: A novel immunochemical marker for mesothelioma

    Am J Surg Pathol

    (1996)
  • RL Attanoos et al.

    Mesothelioma-binding antibodies: Thrombomodulin, OV 632 and HBME-1 and their use in the diagnosis of malignant mesothelioma

    Histopathology

    (1996)
  • NG Ordóñez

    Value of thrombomodulin immunostaining in the diagnosis of mesothelioma

    Histopathology

    (1997)
  • V Ascoli et al.

    The diagnostic value of thrombomodulin immunolocalization in serous effusions

    Arch Pathol Lab Med

    (1995)
  • AD Kennedy et al.

    HBME-1 and antithrombomodulin in the differential diagnosis of malignant mesothelioma of pleura

    J Clin Pathol

    (1997)
  • T Oikawa et al.

    Production of endothelin-1 and thrombomodulin by human pancreatic cancer cells

    Br J Cancer

    (1994)
  • NG Ordóñez

    Role of immunohistochemistry in distinguishing epithelial peritoneal mesotheliomas from peritoneal and ovarian serous carcinomas

    Am J Surg Pathol

    (1998)
  • SJ Kim et al.

    Thrombomodulin is a new biological and prognostic marker for breast cancer: An immunohistochemical study

    Anticancer Res

    (1997)
  • CA Blobel et al.

    Cytokeratins in normal lung and lung carcinomas. I. Adenocarcinomas, squamous cell carcinomas and cultured cell lines

    Virchows Arch [Cell Pathol]

    (1984)
  • GA Blobel et al.

    The intermediate filament cytoskeleton of malignant mesotheliomas and its diagnostic significance

    Am J Pathol

    (1985)
  • R Moll et al.

    Expression of keratin 5 as a distinctive feature of epithelial and biphasic mesotheliomas

  • J Clover et al.

    Anti-cytokeratin 56: A positive marker for epithelioid mesothelioma

    Histopathology

    (1997)
  • NG Ordóñez

    Value of cytokeratin 56 immunostaining in distinguishing epithelial mesothelioma of the pleura from lung adenocarcinoma

    Am J Surg Pathol

    (1998)
  • C Andressen et al.

    Calcium-binding proteins: Selective markers of nerve cells

    Cell Tissue Res

    (1993)
  • AP Dei Tos et al.

    Calretinin: A novel tool for diagnostic immunohistochemistry

    Adv Anat Pathol

    (1998)
  • MCP Barberis et al.

    Calretinin: A selective marker of normal and neoplastic mesothelial cells in serous effusions

    Acta Cytol

    (1997)
  • MPG Leers et al.

    E-cadherin and calretinin: A useful combination of immunochemical markers for differentiation between mesothelioma and metastatic adenocarcinoma

    Histopathology

    (1998)
  • NG Ordóñez

    Value of calretinin immunostaining in differentiating epithelial mesothelioma from lung adenocarcinoma

    Mod Pathol

    (1998)
  • B Geiger et al.

    Cadherins

    Annu Rev Cell Biol

    (1992)
  • M Takeichi

    Cadherin cell adhesion receptors as a morphogenetic regulators

    Science

    (1991)
  • C Redies et al.

    Differential expression of N- and R-cadherin in functional neuronal systems and other structures of the developing chicken brain

    J Comp Neurol

    (1993)
  • A Peralta-Soler et al.

    N-cadherin involvement in cardiac myocyte interaction and myofibrillogenesis

    Dev Biol

    (1994)
  • A Peralta-Soler et al.

    Expression of E-cadherin and N-cadherin in surface epithelial-stromal tumors of the ovary distinguishes mucinous from serous and endometrioid tumors

    Hum Pathol

    (1997)
  • TA Brown et al.

    Human keratinocytes express a new CD44 core protein (CD44E) as a heparin-sulfate intrinsic membranes proteoglycan with additional exons

    J Cell Biol

    (1991)

    • Cited by (108)

    • Malignant and Borderline Mesothelial Tumors of the Pleura

      2018, Practical Pulmonary Pathology: A Diagnostic Approach A Volume in the Pattern Recognition Series

    • Are oestrogens and genetic predisposition etiologic factors in the development of clear cell carcinoma of the peritoneum?

      2013, Medical Hypotheses

    • Malignant pleural mesothelioma in US automotive mechanics: Reported vs expected number of cases from 1975 to 2007

      2012, Regulatory Toxicology and Pharmacology
      Citation Excerpt :

      First, prior to 1975 there was a relative lack of specific and consistent diagnostic techniques available to clinicians and pathologists for this disease. There have been vast improvements over the years, particularly with the development of specific immumohistochemical markers that have enhanced the assessment and proper diagnosis of mesothelioma, providing an improved ability to more accurately distinguish “borderline” tumors (Battifora and Kopinski, 1985; Ordonez, 1999). Also, the likelihood of a case being specifically referred to as an “automotive” mechanic, rather than simply a general “mechanic” is higher in the post-1975 era, primarily due to an increased awareness of potential risks to workers exposed to asbestos, such as automotive mechanics (NIOSH, 1975).

    • Malignant and Borderline Mesothelial Tumors of the Pleura

      2011, Practical Pulmonary Pathology E-Book: A Diagnostic Approach, Second Edition

    • Malignant and Borderline Mesothelial Tumors of the Pleura

      2011, Practical Pulmonary Pathology: A Diagnostic Approach A Volume in the Pattern Recognition Series

    • Immunohistology of Lung and Pleural Neoplasms

      2011, Diagnostic Immunohistochemistry
    View all citing articles on Scopus
    View full text
    Copyright © 1999 Published by Elsevier Inc.